Epilepszia: ki dolgozik rajta

Intézményenként egy kártya. Válassz célpontot, és csak az azon dolgozó csoportok maradnak.

• Minden célpont
• NMDA 0
• mTOR 3
• SCN1A 6
• SCN2A 2
• HMGB1 0
• PPAR 0
• BDNF 1
• NLRP3 0
• TLR4 0
• NRF2 0
• PTEN 0
• AKT 0
• PI3K 0
• IDH 0
• GLP-1 0
• IL-1 1
• JAK 0
• GPX4 0
• AMPK 0
• CTNNB1 1
• MAPK 0
• APOE 0
• COX-2 0
• SGLT2 0
• SIRT1 0
• STING 0
• TNF 0
• ERK 1
• HIF-1 0
• STAT3 0
• TP53 0
• TREM2 0
• CGRP 0
• HDAC 0
• MAPT 0
• YAP 0
• APP 0
• CXCR4 0
• HSP90 0
• IL-6 0
• JNK 0
• MDM2 0
• NOTCH1 0
• NOTCH3 0
• PD-1 0
• PINK1 0
• AQP4 0
• AR 0
• B7-H3 0
• BACE1 0
• BCL-2 0
• BRAF 0
• BRD4 0
• CD47 0
• DMD 0
• DPP-4 0
• FGFR 0
• FTO 0
• G6PD 0
• GBA1 0

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• European Commission (Horizon Europe) · HORIZON-ERC

  From single neuron to brain: multi-level strategy and digital twins for personalized prediction of treatment (Neuron2Brain)

  Universita Degli Studi di Genova· Genova, Olaszország· EU contribution 1 500 000 EUR· until 2032. febr.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Unravelling the Role of Cerebral Amyloid-beta Angiopathy in Epilepsy: Inflammatory Pathways and Interneuron Dysfunction (EPICAA)

  Ludwig-Maximilians-Universitaet Muenchen· Planegg, Németország· EU contribution 217 965 EUR· until 2029. febr.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-GF

  The role of subcortical structures in perceptual consciousness: a causal investigation (StimConscious)

  Katholieke Universiteit Leuven· Leuven, Belgium· EU contribution 424 129 EUR· until 2030. jan.· 3 countries

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-ERC-POC

  Standardized patient‑friendly computational language mapping to guide epilepsy surgery (SPEEDY-Clinic)

  Institut National de la Sante Et de la Recherche Medicale· Paris, Franciaország· EU contribution 150 000 EUR· until 2028. jún.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  High-throughput screen for disfunctions in GABA-switch in human neuronal models of SNAREopathies

  Kobenhavns Universitet· Kobenhavn, Dánia· EU contribution 247 553 EUR· until 2028. okt.

  The disease is named only in the funder's project summary, not in the title.

5 of 64 running projects, newest first. Listed amounts together: 184,0 M EUR.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Vizsgálatok, amelyek regiszteradata szerint az egyéni résztvevői adatokat (IPD) megosztják.

• Retinal OCT Changes and Biomarkers in Drug-Resistant Epilepsy

  NCT07716930· Kemal Tutkavul· Forrás

Publikációk erről a betegségről egy MeSH-módszerkifejezés szerint, például szekvenálási vagy képalkotó módszerre.

• Single-Cell Analysis 8
• Organoids 13
• Mendelian Randomization Analysis 36
• CRISPR-Cas Systems 9
• Gene Expression Profiling 28
• Sequence Analysis, RNA 4
• Whole Genome Sequencing 14
• Exome Sequencing 114
• Proteomics 23
• Metabolomics 23
• Mass Spectrometry 7
• Flow Cytometry 3
• Immunohistochemistry 21
• Liquid Biopsy 1
• Xenograft Model Antitumor Assays 2
• Positron-Emission Tomography 70
• Magnetic Resonance Imaging 572
• Machine Learning 112
• Deep Learning 78
• Cohort Studies 313
• Genome-Wide Association Study 37

• ComicGTN infers disease-associated rare cell states from single-cell multiomic data using DNA sequence-augmented graph transformer networks.

  Genome Res, 2026. aug.

• Integrative single-cell and spatial transcriptomics combined with machine learning to discover complement-associated biomarkers in temporal lobe epilepsy with hippocampal sclerosis.

  Funct Integr Genomics, 2026. júl.

• Integrative Drug-Target Causal Analysis, Single-Cell Sequencing and In-Vivo Validation for Dissecting Molecular Mechanisms Underlying Focal Epilepsy.

  CNS Neurosci Ther, 2026. jún.

• Optimized nuclei isolation and snRNA-seq reveal oligodendrocyte pathway dysregulation in MOGHE brain tissue from pediatric patients.

  Sci Rep, 2026. máj.

• Single-cell multiomics data analysis of potential receptors and therapeutic drugs for epilepsy patients comorbid with depression.

  PLoS One, 2026. ápr.

• Single cell protein profiling of focal cortical dysplasia in a patient requiring multiple resections.

  Acta Neuropathol Commun, 2026. márc.

• Single-Cell Dissection of the SPP1-CD44 Axis Reveals Microglia-Astrocyte Crosstalk Driving Neuroinflammation in Temporal Lobe Epilepsy.

  Mol Neurobiol, 2026. jan.

• Multi-omics reveals that genes linked to succinylation regulate the onset of epilepsy through metabolic reprogramming.

  Mamm Genome, 2025. dec.

Megmutatjuk, a betegség mely célpontjait említi az absztrakt, és onnan a rajtuk dolgozókhoz jutsz.